Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Flu B Virus Strain Victoria Is Good Choice As Vaccine Component - Wyeth

Executive Summary

Wyeth's preliminary data on B/Victoria/504/2000 suggest that it is "an excellent strain" for use in the manufacture of the trivalent flu vaccine.

You may also be interested in...

Influenza vaccine

Manufacturers may choose from more than one B/Sichuan/379/99-like strain for the influenza B strain to be used in the manufacture of flu vaccine for the 2001-2002 season, FDA's Vaccine & Related Biological Products Advisory Committee concludes at March 9 meeting. B/Victoria/504/2000, B/Johannesburg/5/99 and B/Guangdong/120/2000 are among strains that could be selected by manufacturers. The influenza A strains will be the same as in 2000, A/New Caledonia/99 and A/Panama/99 (1"The Pink Sheet" Feb. 5, p. 9)

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts